Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronny Drapkin

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Cancer Research|December 17, 2015
It's Totally Tubular....Riding The New Wave of Ovarian Cancer ResearchRuth Perets, Ronny Drapkin
The Journal of Pathology|March 2, 2018
Precious GEMMs: emergence of faithful models for ovarian cancer researchSarah Stuckelberger, Ronny Drapkin
The Journal of Clinical Investigation|June 1, 2021
Tumor innervation: peripheral nerves take control of the tumor microenvironmentStefan M Gysler, Ronny Drapkin
Nature Protocols|September 1, 2012
Primary culture and immortalization of human fallopian tube secretory epithelial cellsAlison M Karst, Ronny Drapkin
F1000 Medicine Reports|November 15, 2011
The new face of ovarian cancer modeling: better prospects for detection and treatmentAlison M Karst, Ronny Drapkin
Pharmacology & Therapeutics|March 22, 2020
The tubal epigenome - An emerging target for ovarian cancerHunter D Reavis, Ronny Drapkin
Journal of Oncology|September 12, 2009
Ovarian cancer pathogenesis: a model in evolutionAlison M Karst, Ronny Drapkin
Current Opinion in Obstetrics & Gynecology|November 30, 2016
Pathogenesis and heterogeneity of ovarian cancerPaul T Kroeger, Ronny Drapkin
Reproductive Biology and Endocrinology : RB&E|July 7, 2014
The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesisMegan M Emori, Ronny Drapkin
Frontiers in Oncology|August 30, 2013
Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental PlatformsPaul Michael Jones, Ronny Drapkin
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Cancer Research|December 17, 2015
It's Totally Tubular....Riding The New Wave of Ovarian Cancer ResearchRuth Perets, Ronny Drapkin
The Journal of Pathology|March 2, 2018
Precious GEMMs: emergence of faithful models for ovarian cancer researchSarah Stuckelberger, Ronny Drapkin
The Journal of Clinical Investigation|June 1, 2021
Tumor innervation: peripheral nerves take control of the tumor microenvironmentStefan M Gysler, Ronny Drapkin
Nature Protocols|September 1, 2012
Primary culture and immortalization of human fallopian tube secretory epithelial cellsAlison M Karst, Ronny Drapkin
F1000 Medicine Reports|November 15, 2011
The new face of ovarian cancer modeling: better prospects for detection and treatmentAlison M Karst, Ronny Drapkin
Pharmacology & Therapeutics|March 22, 2020
The tubal epigenome - An emerging target for ovarian cancerHunter D Reavis, Ronny Drapkin
Journal of Oncology|September 12, 2009
Ovarian cancer pathogenesis: a model in evolutionAlison M Karst, Ronny Drapkin
Current Opinion in Obstetrics & Gynecology|November 30, 2016
Pathogenesis and heterogeneity of ovarian cancerPaul T Kroeger, Ronny Drapkin
Reproductive Biology and Endocrinology : RB&E|July 7, 2014
The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesisMegan M Emori, Ronny Drapkin
Frontiers in Oncology|August 30, 2013
Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental PlatformsPaul Michael Jones, Ronny Drapkin
Pageof 18